BioCatalystWatch
SGMTWorkspace / SGMT / OverviewCompany library
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc.

Sagimet Biosciences Inc. (SGMT)

Website

Price
Market cap
Next catalystExpected 2026TVB-3567 — SB3567-CLIN-001 · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

TVB-3567

FASN

PreINDP1P2P3FilingApproved
Upcoming / outlook

Denifanstat

FASN

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

TVB-3567

FASN

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

TVB-3567

FASN

PreINDP1P2P3FilingApproved
Upcoming / outlook

TVB-3567

FASN

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Denifanstat

FASN

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

Partner / License out

Denifanstat

FASN

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

Denifanstat

FASN

Denifanstat

FASN

PreINDP1P2FilingApproved
Denifanstat

FASN

PreINDP1P2P3FilingApproved

FASN × THR-β

PreINDP1P3FilingApproved
Upcoming / outlook

FASN × THR-β

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status
1M1M

Market Reaction / Supply Context

Market Structure

SGMT PR & News

PR & News

SGMT SEC archive